Treatment of Great Saphenous Vein Varicosities
- Conditions
- Varicose Veins
- Interventions
- Procedure: Endovenous chemical ablation with Trendelenburg's operation (eCAT)
- Registration Number
- NCT05655416
- Lead Sponsor
- Al-Azhar University
- Brief Summary
Venous insufficiency at lower extremities may result in clinical problems from cosmetic issues to ulcerations. When the frequency of venous insufficiency and its related problems are considered besides their diversity, it is encountered as a public health issue. This pathology is reported to affect 40% of women and 20% of men.1 Patients with varicose veins may complain of unsightly appearance, aching, heaviness, pruritus, and early fatigue of the affected leg. These symptoms worsen with prolonged standing and sitting and are relieved by elevation of the leg above the level of the heart. Also, mild edema is often present. More severe signs include thrombophlebitis, hyperpigmentation, lipodermatosclerosis, ulceration, and bleeding
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Not specified
- Target Recruitment
- 55
- Patients presented by primary VV of the LL complaining of Leg pain cosmetic disfigurement, leg ulcer, itching, or pigmentation at LL
- the incompetence of the saphenofemoral junction (SFJ) and or saphenopopliteal junction (SPJ).
- Lower limb involvement by any of the following conditions; secondary VV, recurrent VV, lymphedema, acute superficial thrombophlebitis, arterio-venous fistula (congenital or acquired), congenital anomalies of the venous system, general comorbidities, skin infection or ischemia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Lower limb varicose vein Endovenous chemical ablation with Trendelenburg's operation (eCAT) -
- Primary Outcome Measures
Name Time Method GSV Patency at one year post operative Great saphenous Vein Patency: is a categorical outcome that will be assesd by dopler ultrasound. it may be patent or partilly occluded or completely occluded or recanalized.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Walied Khereba
🇪🇬Zagazig, Egypt